Thalidomide in patients with multiple myeloma and renal failure

被引：40
|
作者：
Fakhouri, F [1 ]
Guerraoui, H
Presne, C
Peltier, J
Delarue, R
Muret, P
Knebelmann, B
机构：
[1] Hop Necker Enfants Malad, APHP, Serv Nephrol, Paris, France
[2] Hop Sud, Serv Nephrol, Amiens, France
[3] Hop Necker Enfants Malad, Hematol Serv, Paris, France
[4] Hop Jean Minjoz, Serv Pharmacol, F-25030 Besancon, France
来源：
BRITISH JOURNAL OF HAEMATOLOGY | 2004年 / 125卷 / 01期
关键词：
thalidomide; multiple myeloma; pharmacokinetics; renal failure;
D O I：
10.1111/j.1365-2141.2004.04875.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：96 / 97
页数：3
相关论文
共 50 条
  • [41] Renal failure in multiple myeloma: reversibility and impact on the prognosis
    Knudsen, LM
    Hjorth, M
    Hippe, E
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2000, 65 (03) : 175 - 181
  • [42] Multiple Myeloma and Renal Failure: Mechanisms, Diagnosis, and Management
    Kundu, Sumana
    Jha, Surajkumar B.
    Rivera, Ana P.
    Monar, Gabriela V. Flores
    Islam, Hamza
    Puttagunta, Sri Madhurima
    Islam, Rabia
    Sange, Ibrahim
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (02)
  • [43] Prognostic factors in multiple myeloma complicated with renal failure
    Chavynchak, R. B.
    Rekhtina, I. G.
    TERAPEVTICHESKII ARKHIV, 2008, 80 (01) : 84 - 88
  • [44] Effect of thalidomide on stem cell collection and engraftment in patients with multiple myeloma
    I M Ghobrial
    A Dispenzieri
    K L Bundy
    D A Gastineau
    S V Rajkumar
    T M Therneau
    M Q Lacy
    T E Witzig
    M R Litzow
    B R Christensen
    S Hayman
    C G Pribula
    M A Gertz
    Bone Marrow Transplantation, 2003, 32 : 587 - 592
  • [45] Renal failure in multiple myeloma: something new on the horizon
    Offidani, Massimo
    Corvatta, Laura
    BRITISH JOURNAL OF HAEMATOLOGY, 2017, 176 (06) : 845 - 846
  • [46] Thalidomide maintenance therapy for patients with multiple myeloma: Meta-analysis
    Kagoya, Yuki
    Nannya, Yasuhito
    Kurokawa, Mineo
    LEUKEMIA RESEARCH, 2012, 36 (08) : 1016 - 1021
  • [47] Salvage therapy with thalidomide in patients with advanced relapsed/refractory multiple myeloma
    Tosi, P
    Zamagni, E
    Cellini, C
    Ronconi, S
    Patriarca, F
    Ballerini, F
    Musto, P
    Di Raimondo, F
    Ledda, A
    Lauria, F
    Masini, L
    Gobbi, M
    Vacca, A
    Ria, R
    Cangini, D
    Tura, S
    Baccarani, M
    Cavo, M
    HAEMATOLOGICA, 2002, 87 (04) : 408 - 414
  • [48] Effect of thalidomide on stem cell collection and engraftment in patients with multiple myeloma
    Ghobrial, IM
    Dispenzieri, A
    Bundy, KL
    Gastineau, DA
    Rajkumar, SV
    Therneau, TM
    Lacy, MQ
    Witzig, TE
    Litzow, MR
    Christensen, BR
    Hayman, S
    Pribula, CG
    Gertz, MA
    BONE MARROW TRANSPLANTATION, 2003, 32 (06) : 587 - 592
  • [49] In vitro study of the hypercoagulable state in multiple myeloma patients treated or not with thalidomide
    Petropoulou, Anna D.
    Gerotziafas, Grigoris T.
    Samama, Meyer M.
    Hatmi, Mohamed
    Rendu, Francine
    Elalamy, Ismail
    THROMBOSIS RESEARCH, 2008, 121 (04) : 493 - 497
  • [50] Single dose pharmacokinetic study of thalidomide in patients with multiple myeloma.
    Pathak, A.
    Malhotra, J.
    Raina, V
    Arya, D. S.
    Gupta, Y. K.
    ACTA PHARMACOLOGICA SINICA, 2006, 27 : 218 - 218
12345